NCT04939636

Brief Summary

A longitudinal, double-blinded, randomized, trial, with a 10 month follow-up period will be conducted between July 2021 to May 2022

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2020

Completed
9 months until next milestone

First Posted

Study publicly available on registry

June 25, 2021

Completed
24 days until next milestone

Study Start

First participant enrolled

July 19, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2022

Completed
Last Updated

December 28, 2022

Status Verified

December 1, 2022

Enrollment Period

11 months

First QC Date

October 13, 2020

Last Update Submit

December 27, 2022

Conditions

Keywords

Vitamin D supplementationConscriptsMilitary sevicePhysical preformance

Outcome Measures

Primary Outcomes (4)

  • Prevalence of vitamin D between study groups (Baseline, no intervention)

    Prevalence of vitamin D measured serum vitamin D 25(OH)D concentration. Vitamin D considered as sufficient if the serum 25(OH)D concentration is ≥75 nmol/L, insufficient if \<75 nmol/L, deficient if \<50 nmol/L and critical deficiency \< 25 nmol/L.

    0 months Baseline

  • Prevalence of vitamin D between study groups (Intervention I vs.II)

    Prevalence of vitamin D measured serum vitamin D 25(OH)D concentration. Vitamin D considered as sufficient if the serum 25(OH)D concentration is ≥75 nmol/L, insufficient if \<75 nmol/L, deficient if \<50 nmol/L and critical deficiency \< 25 nmol/L.

    3 months

  • Prevalence of vitamin D between study groups (Intervention I vs.II)

    Prevalence of vitamin D measured serum vitamin D 25(OH)D concentration. Vitamin D considered as sufficient if the serum 25(OH)D concentration is ≥75 nmol/L, insufficient if \<75 nmol/L, deficient if \<50 nmol/L and critical deficiency \< 25 nmol/L.

    app.6-7 months

  • Prevalence of vitamin D between study groups (Intervention I vs.II)

    Prevalence of vitamin D measured serum vitamin D 25(OH)D concentration. Vitamin D considered as sufficient if the serum 25(OH)D concentration is ≥75 nmol/L, insufficient if \<75 nmol/L, deficient if \<50 nmol/L and critical deficiency \< 25 nmol/L.

    app. 9-10 months

Secondary Outcomes (61)

  • Serum parathyroid hormone

    0 months baseline

  • Serum parathyroid hormone

    3 months

  • Serum parathyroid hormone

    app. 6-7 months

  • Serum parathyroid hormone

    app. 9-10 months

  • Serum calcium

    0 months baseline

  • +56 more secondary outcomes

Study Arms (2)

Vitamin D3 capsules 4000IU/100µg

ACTIVE COMPARATOR

Get Vitamin D3 capsules 4000IU/100µg.

Dietary Supplement: Vitamin D3 capsules 4000IU/100µg.

Vitamin D3 capsules 600IU/15µg

ACTIVE COMPARATOR

Get Vitamin D3 capsules 600IU/15µg.

Dietary Supplement: Vitamin D3 capsules 600IU/15µg.

Interventions

Vitamin D3 supplementation

Vitamin D3 capsules 4000IU/100µg

Vitamin D3 supplementation

Vitamin D3 capsules 600IU/15µg

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Participating in military service at the Estonian Defence Forces
  • Voluntary participation in the study

You may not qualify if:

  • Refusal of a conscript or withdrawal of consent
  • Departure from military unit
  • Force majeure
  • Acute trauma or illness in the course of conscript requiring hospital treatment
  • Serious side effects or allergies to vitamin D capsules

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kuperjanov Infantry Battalion, Estonian Defence Forces

Võru, Võrumaa, 50400, Estonia

Location

Related Publications (18)

  • Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982 Nov;36(5):936-42. doi: 10.1093/ajcn/36.5.936.

    PMID: 7137077BACKGROUND
  • Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006 Jul;84(1):18-28. doi: 10.1093/ajcn/84.1.18.

    PMID: 16825677BACKGROUND
  • Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005 Jul;16(7):713-6. doi: 10.1007/s00198-005-1867-7. Epub 2005 Mar 18.

    PMID: 15776217BACKGROUND
  • EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Turck D, Bresson JL, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Nowicka G, Pentieva K, Sanz Y, Siani A, Sjodin A, Stern M, Tome D, Van Loveren H, Vinceti M, Willatts P, Lamberg-Allardt C, Przyrembel H, Tetens I, Dumas C, Fabiani L, Ioannidou S, Neuhauser-Berthold M. Dietary reference values for vitamin K. EFSA J. 2017 May 22;15(5):e04780. doi: 10.2903/j.efsa.2017.4780. eCollection 2017 May.

    PMID: 32625486BACKGROUND
  • Goodman GP, Schoenfeld AJ, Owens BD, Dutton JR, Burks R, Belmont PJ. Non-emergent orthopaedic injuries sustained by soldiers in Operation Iraqi Freedom. J Bone Joint Surg Am. 2012 Apr 18;94(8):728-35. doi: 10.2106/JBJS.K.00129.

    PMID: 22517389BACKGROUND
  • Hughes JM, Smith MA, Henning PC, Scofield DE, Spiering BA, Staab JS, Hydren JR, Nindl BC, Matheny RW Jr. Bone formation is suppressed with multi-stressor military training. Eur J Appl Physiol. 2014 Nov;114(11):2251-9. doi: 10.1007/s00421-014-2950-6. Epub 2014 Jul 16.

    PMID: 25027064BACKGROUND
  • Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007 Mar;85(3):860-8. doi: 10.1093/ajcn/85.3.860.

    PMID: 17344510BACKGROUND
  • Inklebarger J, Griffin M, Taylor MJ, Dembry RB. Femoral and tibial stress fractures associated with vitamin D insufficiency. J R Army Med Corps. 2014 Mar;160(1):61-3. doi: 10.1136/jramc-2013-000085. Epub 2013 Jun 26.

    PMID: 24109098BACKGROUND
  • Knapik JJ, East WB. History of United States Army physical fitness and physical readiness training. US Army Med Dep J. 2014 Apr-Jun:5-19.

    PMID: 24706237BACKGROUND
  • Kull M Jr, Kallikorm R, Tamm A, Lember M. Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country. BMC Public Health. 2009 Jan 19;9:22. doi: 10.1186/1471-2458-9-22.

    PMID: 19152676BACKGROUND
  • Laaksi IT, Ruohola JP, Ylikomi TJ, Auvinen A, Haataja RI, Pihlajamaki HK, Tuohimaa PJ. Vitamin D fortification as public health policy: significant improvement in vitamin D status in young Finnish men. Eur J Clin Nutr. 2006 Aug;60(8):1035-8. doi: 10.1038/sj.ejcn.1602414. Epub 2006 Feb 15.

    PMID: 16482069BACKGROUND
  • Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamaki H, Ylikomi T. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007 Sep;86(3):714-7. doi: 10.1093/ajcn/86.3.714.

    PMID: 17823437BACKGROUND
  • Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamaki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis. 2010 Sep 1;202(5):809-14. doi: 10.1086/654881. No abstract available.

    PMID: 20632889BACKGROUND
  • Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect. 2009 Oct;137(10):1396-404. doi: 10.1017/S0950268809002404. Epub 2009 Mar 19.

    PMID: 19296870BACKGROUND
  • Maloney SR, Almarines D, Goolkasian P. Vitamin D levels and monospot tests in military personnel with acute pharyngitis: a retrospective chart review. PLoS One. 2014 Jul 10;9(7):e101180. doi: 10.1371/journal.pone.0101180. eCollection 2014.

    PMID: 25009977BACKGROUND
  • Ong GS, Walsh JP, Stuckey BG, Brown SJ, Rossi E, Ng JL, Nguyen HH, Kent GN, Lim EM. The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. J Clin Endocrinol Metab. 2012 Sep;97(9):3138-45. doi: 10.1210/jc.2012-1429. Epub 2012 Jun 28.

    PMID: 22745247BACKGROUND
  • Ruohola JP, Laaksi I, Ylikomi T, Haataja R, Mattila VM, Sahi T, Tuohimaa P, Pihlajamaki H. Association between serum 25(OH)D concentrations and bone stress fractures in Finnish young men. J Bone Miner Res. 2006 Sep;21(9):1483-8. doi: 10.1359/jbmr.060607.

    PMID: 16939407BACKGROUND
  • Wierniuk A, Wlodarek D. Estimation of energy and nutritional intake of young men practicing aerobic sports. Rocz Panstw Zakl Hig. 2013;64(2):143-8.

    PMID: 23987084BACKGROUND

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Cholecalciferol

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Officials

  • Madis Rahu, PhD

    University of Tartu

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
Computed randomization will be used to divide conscripts into two groups; the intervention group, who received vitamin D3 capsules (4000 IU/100µg) or the intervention group, who received vitamin D3 capsules (600 IU/15µg) .
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Triple blinded randomized placebo-controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, MD, Orthopaedic surgeon

Study Record Dates

First Submitted

October 13, 2020

First Posted

June 25, 2021

Study Start

July 19, 2021

Primary Completion

June 16, 2022

Study Completion

June 16, 2022

Last Updated

December 28, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations